By exclusively licensing in Illinois products of a multi-state network that implements cutting edge methods & technology, NuMed Partners Illinois is uniquely structured for rapid growth.
NuMed will have a unique focus on medical product innovation and will track the therapeutic benefits of those products through working relationships with academic, health care, and other key institutions. Both directly and through its strategic partners, NuMed has assembled a diverse and talented Management Team and Advisory Board with experience in and beyond the fields of agronomy, engineering, medicine, pharmaceuticals, biotechnology, and drug or rehabilitation therapy.
NuMed will establish and operate a state of the art production facility for medically focused marijuana infused products integrated into a licensed Illinois cultivation center.
The primary challenge with Medical Marijuana Infused Products (MIPs) is administering doses of CBD that are high enough to generate therapeutic effects without unwanted psychoactive effects of THC. To meet this challenge, NuMed has focused on multiple, targeted delivery systems with the intention of creating a portfolio of intellectual property specific to MIPs.
This process has included (1) developing new and proprietary methods of targeted delivery, and (2) acquiring licensing rights from or forming strategic alliances with medical firms to adapt technologies proven to provide therapeutic benefits in other medical contexts to this unique and rapidly expanding market niche.
The demonstrated benefits of this strategy, in the context of medicines derived from marijuana, include:
Testing of proprietary delivery systems is currently underway in Arizona and Colorado. Once they are thoroughly vetted, we will distribute a line of products targeting a range of conditions, calibrated to precise dosing levels.
We applaud Illinois’ decision to award our affiliate, NuMed Illinois, three medical marijuana dispensary licenses. NuMed has opened its Urbana and East Peoria locations in Q4 2016, and will open its Chicago location in early 2017.